We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Technology for Sampling Body Liquids in Confined Spaces to Enable Early Cancer Detection

By LabMedica International staff writers
Posted on 17 Sep 2024

Body fluids—such as blood, pancreatic juice, urine, and mucus—contain valuable information about chemical composition, biomarkers, bacterial colonies, and other key components. More...

This information aids researchers in understanding the mechanisms of various diseases, including cancer, and monitoring patients' health. Wireless mobile robots at the millimeter scale have shown promise in navigating confined spaces to collect these fluids due to their small size and agile movement. However, these devices have lacked the ability to sample liquids effectively because of the absence of efficient triggering and sealing mechanisms at such small scales. Researchers have now addressed this gap by developing technology for sampling body fluids in narrow and complex spaces, which could enable early detection of diseases like cancer.

A research team at Vanderbilt University (Nashville, TN, USA) has developed millimeter-scale soft capsules made of hydrogel-and-elastomer hybrids, which are controlled using external magnetic fields. These devices, according to the researchers, can be delivered and retrieved via a thin catheter and are capable of navigating tubular structures that are otherwise inaccessible to catheters. The soft capsules are coated with a specialized wetting property that enables them to efficiently pump liquids inside. As reported in Science Advances, the integration of on-demand triggering, sampling, and sealing mechanisms, along with agile group locomotion, allowed the team to demonstrate precise control of these soft capsules. They successfully navigated and sampled body fluids in a phantom and ex vivo animal organ, guided by ultrasound and X-ray medical imaging.

“The millimeter-scale soft capsules introduced in this work open avenues for minimally invasive and targeted liquid biopsy in confined spaces such as the pancreas duct, enabling early disease diagnosis and providing insights into disease development through the sampling, retrieval, and analysis of abundant chemicals within organs,” said Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt University, who led the research.

Related Links:
Vanderbilt University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.